Full Text View
Tabular View
No Study Results Posted
Related Studies
Secretin Enhanced MRCP for Evaluation of Pancreatic Duct in Pediatric Population
This study has been terminated.
( Poor patient enrollment due to logistical issues )
Study NCT00621283   Information provided by Massachusetts General Hospital
First Received: January 22, 2008   Last Updated: January 27, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acute Recurrent Pancreatitis
Chronic Pancreatitis
Additional conditions recognized in this trial
Pancreatitis
Pancreatitis, Chronic
More general conditions related to this trial
Digestive System Diseases
Pancreatic Diseases
Interventions listed in this trial
RG1068 (Synthetic Human Secretin)
Additional drug interventions recognized in this trial
Secretin
More general drug interventions related to this trial
Gastrointestinal Agents
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Massachusetts General Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services